On Invalid Date, Twist Bioscience (NASDAQ: TWST) reported Q4 2022 earnings per share (EPS) of -$0.74, up 18.68% year over year. Total Twist Bioscience earnings for the quarter were -$41.82 million. In the same quarter last year, Twist Bioscience's earnings per share (EPS) was -$0.91.
On Invalid Date, Twist Bioscience (NASDAQ: TWST) reported Q4 2022 revenue of $54.24 million up 29.09% year over year. In the same quarter last year, Twist Bioscience's revenue was $42.02 million.
What was TWST's revenue growth in the past year?
As of Q1 2023, Twist Bioscience's revenue has grown 47.61% year over year. This is 36.98 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 10.63%. Twist Bioscience's revenue in the past year totalled $215.79 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.